Investor Type | Firm |
Industries | BioTech • Life Science |
Investing | United Kingdom |
Oxford Sciences Innovation (OSI), also known as Oxford Science Enterprises (OSE), is an independent investment company founded in 2015 with the goal of transforming the best ideas from the University of Oxford into world-class businesses that address some of the most significant global challenges. They have formed a unique partnership with the University of Oxford, a leading research institution, to create a science-business ecosystem that has markedly increased investment in university spinouts. They focus on investing in three main sectors: Deep Tech, Life Sciences, and Health Tech. In the Deep Tech sector, they develop technologies that fuel the fourth industrial revolution. In Life Sciences, they collaborate with scientists to turn innovative research into new medicines that improve patient lives. In Health Tech, they support pioneers who are blending healthcare with technology to advance the use of digital tools. OSI plays an integral role throughout the company lifecycle, from the initial funding stage all the way through to exit, demonstrating a commitment to nurturing their portfolio businesses. They present themselves as the first cheque writers and have, over the years, raised over £850 million and invested £775 million into high-impact sectors, resulting in over 45 core portfolio companies, 2 IPOs on NASDAQ, and 8 successful exits. Their hands-on approach has been a key component in elevating the amount of investment into Oxford-based spinouts and has attracted significant talent to the ecosystem they support.